Diversity in Dermatology National Conference 2026
The Diversity in Dermatology (DID) 2026 National Conference is a comprehensive, multi-day educational program designed to advance clinical excellence, access, and innovation in dermatologic care. Through expert-led lectures, case-based discussions, and interdisciplinary perspectives, the conference addresses state-of-the-art medical, pediatric, aesthetic, and complex dermatology topics while emphasizing culturally competent care for diverse and underserved populations. DID 2026 equips dermatology professionals with evidence-based knowledge and practical strategies to improve patient outcomes across all practice settings.
Target Audience
This activity is designed for an audience of physicians, nurses, and physician associates.
Learning Objectives
- Increase their approach to a diverse population of patients.
- State very high level, detailed, and specific details related to common and uncommon disease states.
- Increase cultural competency and how to incorporate new technology and medications into their treatment regimens.
Commercial Support
There is no commercial support for this activity.
Planners and Reviewers
Dorothy Caputo, MA, BSN, RN (President, AKH Inc.)
Rebecca Ann Lakofsky, BSN (Reviewer)
AKH Inc Staff and Planners
BCI Management & Communications Staff and Planners
All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Risha Bellomo
Tracee Blackburn, DMSc, MSIM, PA-C
Thais Delgado, PA-C
Terry faleye, Terry Faleye DMS, MPAS, PA-C
Andrea Hagins
Kendra Joseph, DMSc, PA-C
Divine Mengue
Shanna Miranti
Brittany Scurto Youngblood, PA-C
Cynthia Sershen, DNP, DCNP, FNP-BC
Jade Trevino, Registered Nurse
Risha Bellomo
Tracee Blackburn, DMSc, MSIM, PA-C
Roni Bolton, Nurse Practitioner
Ahuva Cices
ADRIANA Cruz, MD
Diego Dasilva, MD, FAAD
Scott drew, G. Scott Drew, DO, FAAD, FAOCD
Amanda Hill
Naiem Issa, MD, PhD
Meena Julapalli, MD
Walter Liszewski, MD
Ginger Lore, Attorney, Florida Bar
Theodore Rosen, MD
Brittany Scurto Youngblood, PA-C
Elizabeth Swanson, MD, FAAD
Shannon Trotter, DO, FAOCD, FAAD
Kala Washington, American Board of Otolaryngology | American Board of Facial Plastic and Reconstructive Surgery
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and BCI Management & Communications. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 19.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit being awarded: 19.5 ANCC contact hours
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and BCI Management & Communications. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 19.5 contact hour(s) (which includes 10.0 hour(s) of pharmacology).
Available Credit
- 19.50 AANP
- 19.50 AAPA Category 1 CME
- 19.50 AMA PRA Category 1 Credit™
- 19.50 ANCC
- 19.50 Attendance

Facebook
X
LinkedIn
Forward